Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-07-28Clinical Trial Update: A Phase 2 Study to Evaluate the Cardiac and Renal Effects of Short Term Treatment With Elamipretide in Patients Hospitalized With Congestion Due to Heart Failure [Phase 2]
Phase 2 trial evaluating short-term elamipretide for cardiac and renal effects in patients hospitalized with congestion due to heart failure…
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function [Phase 2]
Phase 2 trial evaluating continuous infusions of HNO (Nitroxyl) donor in patients with heart failure and reduced ejection fraction; study co…
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: Tolvaptan for Advanced or Refractory Heart Failure [Phase 4]
A Phase 4 clinical trial of tolvaptan for advanced or refractory heart failure has been terminated.
-
CLINICAL_TRIALS trial_result · 2020-07-24Clinical Trial Update: Abdominal Nerve Blockade in Chronic Heart Failure. [Phase 1, Phase 2]
A clinical trial update on abdominal nerve blockade for heart failure across Phase 1 and Phase 2 has been completed with results posted.
-
FDA approval · 2020-07-24FDA Approved: RAMIPRIL — Supplemental Application (Chartwell RX, LLC.)
The FDA approved a supplemental application for ramipril (generic ramipril) filed by Chartwell RX, LLC., under ANDA 078745.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-07-16FDA Approved: MILRINONE LACTATE IN DEXTROSE — Original Application (Hospira, Inc.)
FDA approves the original Abbreviated New Drug Application for Milrinone lactate in dextrose injection from Hospira, a generic intravenous i…
-
FDA approval · 2020-07-10FDA Approved: VALSARTAN — Supplemental Application (Solco Healthcare US, LLC)
FDA approved a supplemental application for VALSARTAN by Solco Healthcare US, LLC.
-
CLINICAL_TRIALS research · 2020-07-09Clinical Trial Update: Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry
A completed clinical trial registry update on sleep-disordered breathing in heart failure (SchlaHF-Registry) with results posted in 2020.
-
FDA approval · 2020-07-01FDA Approved: FUROSEMIDE — Original Application (Gland Pharma Limited)
FDA approves the original generic application for furosemide from Gland Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2020-06-29Clinical Trial Update: A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001) [Phase 3]
Phase 3 trial of vericiguat in participants with heart failure with reduced ejection fraction (HFrEF) has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2020-06-19Clinical Trial Update: Preemptive Lung Impedance-Guided Therapy in Evolving Acute Heart Failure in Acute Myocardial Infarction Patients [Phase 3]
Phase 3 trial update on preemptive lung impedance-guided therapy in evolving acute heart failure following acute myocardial infarction.
-
FDA approval · 2020-06-11FDA Approved: SODIUM NITROPRUSSIDE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for a generic sodium nitroprusside product manufactured by Mylan Institutional LLC.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Growth Hormone in Ischemic Heart Failure [Phase 3]
Phase 3 clinical trial update evaluating growth hormone in ischemic heart failure has completed.
-
EMA guidance · 2020-06-09Latest data support continued use of ACE inhibitors and ARB medicines during COVID-19 pandemic
EU regulators indicate continued use of ACE inhibitors and ARB medicines is supported by latest data during the COVID-19 pandemic.
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: Effects of Exercise Training on Fluid Instability in Heart Failure Patients [NA]
Clinical trial results on exercise training effects in heart failure patients have been posted after completion.
-
FDA approval · 2020-05-31FDA Approved: FUROSEMIDE — Supplemental Application (Solco Healthcare LLC)
FDA approves a supplemental ANDA for furosemide from Solco Healthcare LLC.
-
FDA approval · 2020-05-28FDA Approved: FUROSEMIDE — Supplemental Application (Ipca Laboratories Limited)
The FDA approved Ipca Laboratories Limited's supplemental application for furosemide under an ANDA, updating the approved product.
-
CLINICAL_TRIALS trial_result · 2020-05-27Clinical Trial Update: Self-Management App for Patients With Left-Ventricular Assist Devices [NA]
A completed clinical trial evaluating a self-management mobile app for patients with left-ventricular assist devices (LVAD) in heart failure…
-
CLINICAL_TRIALS trial_result · 2020-05-20Clinical Trial Update: B-lines Lung Ultrasound Guided ED Management of Acute Heart Failure Pilot Trial [Phase 2]
Phase 2 pilot trial evaluating emergency department management of acute heart failure guided by lung ultrasound B-lines; results have been p…
-
FDA label_change · 2020-05-19FDA Approved: CAPTOPRIL — Supplemental Application (Solco Healthcare US, LLC)
The FDA approved a supplemental application for captopril submitted by Solco Healthcare US, LLC, updating the labeling for the generic drug …
-
FDA approval · 2020-05-19FDA Approved: TOLVAPTAN — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories LLC's original ANDA for tolvaptan, a vasopressin V2 receptor antagonist, as a generic option for treating h…
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Treatment of Predominant Central Sleep Apnoea by Adaptive Servo Ventilation in Patients With Heart Failure [NA]
A completed clinical trial evaluating adaptive servo-ventilation for predominant central sleep apnea in patients with heart failure; results…
-
CLINICAL_TRIALS trial_result · 2020-05-06Clinical Trial Update: Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS [NA]
Clinical trial update for the COAPT study and COAPT CAS, assessing cardiovascular outcomes of MitraClip in heart failure patients with funct…
-
FDA approval · 2020-05-05FDA Approved: FARXIGA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Farxiga (dapagliflozin) from AstraZeneca, adding/ updating labeling to reflect a new indication …
-
FDA approval · 2020-05-05FDA Approved: VALSARTAN — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
The FDA approved Jubilant Cadista's supplemental application for the generic drug valsartan. Valsartan is used to treat hypertension, heart …